Pharmhouse Corp (PHSE) — Capital Reinvestment Ratio
Latest as of September 2023:
1.00x
Pharmhouse Corp (PHSE) has a Capital Reinvestment Ratio of 1.00x as of September 2023, meaning it reinvests 1% of its operating cash flow ($1.00) in capital expenditures ($1.00). For the full cash flow conversion analysis, see Pharmhouse Corp cash flow conversion.
Capital Reinvestment Ratio
1.00x
Capex / Operating Cash Flow
Operating Cash Flow
$1.00
USD
Capital Expenditures
$1.00
USD
Data as of
Sep 2023
Most recent filing
Annual Capital Reinvestment Ratio for Pharmhouse Corp (None–None)
Year-by-year Capital Reinvestment Ratio for Pharmhouse Corp from None to None. See PHSE working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow